Merck & Co., Inc. (NYSE:MRK) is looking forward to expanding its portfolio of drugs mostly administered in the hospital settings for bacterial infections...
Keep Reading →
December 8 - News - Comments
After the market closed on July 30, antibiotic expert Cubist Pharmaceuticals Inc (NASDAQ:CBST) announced two acquisitions worth up to a combined $1....
Keep Reading →
September 15 - News - Comments
To many of your fellow Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) investors, hedge funds are perceived as overrated, outdated investment...
Keep Reading →
September 11 - News - Comments
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age. Although there are more than 8,000 hedge...
Keep Reading →
August 29 - News - Comments
In the eyes of many investors, hedge funds are perceived as bloated, outdated financial vehicles of a forgotten age. Although there are In excess of 8...
Keep Reading →
August 28 - News - Comments
Is Endo Health Solutions Inc (NASDAQ:ENDP) a buy? To many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten...
Keep Reading →
August 27 - News - Comments
In today’s marketplace, there are tons of indicators investors can use to track the equity markets. A couple of the most underrated are hedge fund and...
Keep Reading →
August 27 - News - Comments
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time. Although there...
Keep Reading →
August 26 - News - Comments
With two simultaneous moves that have set the pharmaceutical world on fire, Cubist Pharmaceuticals Inc (NASDAQ:CBST) has triumphantly announced its arrival...
Keep Reading →
August 10 - News - Comments
In June this year, a drug candidate from Cubist Pharmaceuticals Inc (NASDAQ:CBST) received fast track status from the FDA. This product can potentially...
Keep Reading →
August 5 - News - Comments
With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Keep Reading →
August 5 - News - Comments
Cubist Pharmaceuticals Inc (NASDAQ:CBST) surged 10% on July 31, after the company acquired two antibiotic makers, Optimer Pharmaceuticals, Inc. (NASDAQ...
Keep Reading →
August 1 - News - Comments
Shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST) exploded upward on Friday, finishing up over 9%. The company reported strong second-quarter results...
Keep Reading →
July 22 - News - Comments
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds’ portfolio at the end of March. TARO investors should pay attention to an increase...
Keep Reading →
July 1 - News - Comments
A spate of 10 biotechs went public this year, raising over $725 million. As one banker put it, this is a sector “where investors take binary risks,...
Keep Reading →
June 19 - News - Comments
United Therapeutics Corporation (NASDAQ:UTHR) shareholders have witnessed a decrease in hedge fund interest of late. If you’d ask most investors...
Keep Reading →
June 3 - News - Comments
Cubist Pharmaceuticals Inc (NASDAQ:CBST) was in 22 hedge funds’ portfolio at the end of March. CBST investors should pay attention to an increase...
Keep Reading →
May 31 - News - Comments
The Medicines Company (NASDAQ:MDCO) has experienced an increase in hedge fund sentiment recently. At the moment, there are a multitude of metrics investors...
Keep Reading →
May 31 - News - Comments
Small pharma is fighting an uphill battle. Fortunately, this is precisely what inspires a lot of companies to reach for the heavens. Unfortunately, the...
Keep Reading →
May 24 - News - Comments
AstraZeneca plc (ADR) (NYSE:AZN)‘s in a tight spot. The big pharma’s sales and earnings have swung sharply lower recently, with patent expirations...
Keep Reading →
May 15 - News - Comments
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom. Here are three...
Keep Reading →
April 7 - News - Comments
Is Cubist Pharmaceuticals Inc (NASDAQ:CBST) a buy right now? Prominent investors are taking a bearish view. The number of long hedge fund bets stayed...
Keep Reading →
March 26 - News - Comments
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some small-cap stocks to your...
Keep Reading →
March 15 - News - Comments
When considering any stock for your portfolio, don’t be swayed by just the positives. Examine its pros and cons and decide whether its possible...
Keep Reading →
February 5 - News - Comments
